Table 2.

TPO mRNA Expression in Right and Left Liver Lobe, Kidney, Spleen, Lung, and Bone Marrow of Human Fetuses and Preterm Neonates

Pos. (%)Concentration of TPO mRNA (amol/μg RNA)Tissue-Specific TPO mRNA (amol/g tissue)
Range Median Range Median
Liver, right lobe  100 0.04-8.25  0.210  50-17,799  446  
n = 26  
Liver, left lobe  100  0.02-2.94  0.227  33-5,337  505 
n = 25  
Kidney  100  0.01-1.04  0.124  5-1,817 134  
n = 21  
Spleen  88  0.04-1.04  0.217 21-1,454  252  
n = 25  
Lung  76  0.03-0.31 0.143  13-214   55  
n = 17  
Bone marrow  84 0.04-0.65  0.214  ND  ND  
n = 19 
Pos. (%)Concentration of TPO mRNA (amol/μg RNA)Tissue-Specific TPO mRNA (amol/g tissue)
Range Median Range Median
Liver, right lobe  100 0.04-8.25  0.210  50-17,799  446  
n = 26  
Liver, left lobe  100  0.02-2.94  0.227  33-5,337  505 
n = 25  
Kidney  100  0.01-1.04  0.124  5-1,817 134  
n = 21  
Spleen  88  0.04-1.04  0.217 21-1,454  252  
n = 25  
Lung  76  0.03-0.31 0.143  13-214   55  
n = 17  
Bone marrow  84 0.04-0.65  0.214  ND  ND  
n = 19 

TPO cDNA was quantified by competitive PCR, and mRNA concentrations were calculated considering the RT efficiency, the amount of reverse transcribed RNA, and the concentration of total RNA per gram tissue. Median and range include RT-PCR positive samples only.

Abbreviations: n, total number of tissue samples; Pos., fraction of positive samples in TPO RT-PCR; ND, not determined.

Close Modal

or Create an Account

Close Modal
Close Modal